Aslı Kavaz Tufan

Dr. Aslı Kavaz Tufan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2022 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
NCNuran Cetın
Nuran Cetın
EKEvin Kocaturk
Evin Kocaturk
ATAslı Kavaz Tufan
Aslı Kavaz Tufan
ZKZeynep Kusku Kıraz
Zeynep Kusku Kıraz
OAOzkan Alatas
Ozkan Alatas

28 September 2022 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
EAEmine Altay
Emine Altay
HKHikmet Kıztanır
Hikmet Kıztanır
PKPelin Kosger
Pelin Kosger
NCNuran Cetin
Nuran Cetin
ASAyse SULU
Ayse SULU
BUBirsen Ucar
Birsen Ucar

1 September 2022 in Turkish Archives of Pediatrics
Verified
Journal Article
Open access
PBPolat Cengiz Bektaş
Polat Cengiz Bektaş
ATAslı Kavaz Tufan
Aslı Kavaz Tufan
NÇNuran Çetin
Nuran Çetin
CYCoşkun Yarar
Coşkun Yarar
KCKursat Bora Carman
Kursat Bora Carman
Objective: Familial Mediterranean fever is a systemic inflammatory disease characterized by recurrent attacks in the form of fever and inflammation of serous membranes. We aimed to search for neurological signs and symptoms of children with familial Mediterranean fever. Materials and Methods: Medical records database from 2010 to 2020 was screened retrospectively. In total, 625 children with familial Mediterranean fever were included in the study. Neurological symptoms and associated factors were searched. Results: The mean age at onset of familial Mediterranean fever symptoms and time to diagnosis was calculated as 5.12 ± 3.51 years and 7.27 ± 3.9 years, respectively. The neurological symptoms were present in 142 (23.5%) patients. Headache was the most common symptom. During follow-up, different neurologic diseases were diagnosed in 40 familial Mediterranean fever patients and epilepsy was the most frequent disease. The coexistent disease was present in 49.9% of children with familial Mediterranean fever. Juvenile idiopathic arthritis was found to be a risk factor for the neurologic symptom (P < .05). The frequency of neurological symptoms was higher in patients with E148Q mutation (P < .012). Conclusion: The results of the present study revealed that patients with familial Mediterranean fever can present with various central nervous system manifestations. A multidisciplinary approach must be considered in the treatment of these children. Cite this article as: Bektaş PC, Kavas Tufan A, Çetin N, Yarar C, Carman KB. Neurological face of familial mediterranean fever. Turk Arch Pediatr. 2022;57(5):511-515.

11 November 2021 in The Journal of Pediatric Research
Verified
Journal Article
Closed access
NÇNuran Çetin
Nuran Çetin
ATAslı Kavaz Tufan
Aslı Kavaz Tufan
ISİlKnur Ak Sivrikoz
İlKnur Ak Sivrikoz
NANevbahar Akçar
Nevbahar Akçar

1 March 2023 in Children
Verified
Journal Article
Open access
PDF file
ALAyben Leblebici
Ayben Leblebici
GBGÜRKAN BOZAN
GÜRKAN BOZAN
ATAslı Kavaz Tufan
Aslı Kavaz Tufan
EKEylem Kiral
Eylem Kiral
EKEbru Kacmaz
Ebru Kacmaz
Ener Cagri DinleyiciEner Cagri Dinleyici
Ener Cagri Dinleyici
The development of AKI (acute kidney injury) in critically ill patients in pediatric intensive care units (PICUs) is one of the most important factors affecting mortality. There are scoring modalities used to predict mortality in PICUs. We compared the AKIN (Acute Kidney Injury Network) and pRIFLE (pediatric risk, injury, failure, loss, and end stage) AKI classifications and PICU scoring modalities in this study. Methods: A total of 716 children, whose serum creatinine levels were within the normal limits at the time of admission to the PICU between January 2018 and December 2020, were included. Along with the demographic and clinical variables, AKIN and pRIFLE classifications were recorded at the most advanced stage of AKI. Along with the PIM-2, PRISM III, and PELOD-2 scores, the highest value of the pSOFA score was recorded. Results: According to the pRIFLE and AKIN classifications, 62 (8.7%) patients developed kidney injury, which had a statistically significant effect on mortality. The occurrence of renal injury was found to be statistically strongly and significantly correlated with high PRISM III, PELOD-2, and pSOFA scores. When the stages of kidney injury according to the AKIN criteria were compared with the PRISM III, PELOD 2, and pSOFA scores, a significant difference was found between the patients who did not develop AKI and those who developed stage 1, stage 2, and stage 3 kidney injury. For the PRISM III, PELOD 2, and pSOFA scores, there were no significant differences between the stages according to the AKIN criteria. A substantial difference was discovered between the patients who did not develop AKI and those who were in the risk, injury, and failure plus loss stages according to the pRIFLE criteria. According to the PIM-2 ratio and pRIFLE criteria, there was a statistically significant difference between patients in the injury and failure plus loss stages and those who did not develop AKI. Conclusions: Our study is the first pediatric study to show a substantial correlation between the variables associated with the PICU scoring modalities in critically ill children with AKI. Identifying the risk factors for the development of AKI and planning antimicrobial regimens for patients with favorable prognoses at the time of PICU admission could lower mortality rates.

16 January 2022 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
EYEsra Karabağ Yılmaz
Esra Karabağ Yılmaz
SSSeha Kamil Saygili
Seha Kamil Saygili
BGBora Gulhan
Bora Gulhan
NCNur Canpolat
Nur Canpolat
ABAysun Karabay Bayazıt
Aysun Karabay Bayazıt
FOFatih Ozaltin
Fatih Ozaltin